To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment.
Yehan Z, Sheng Q, Hong Y, Jiayu L, Jun H, Juan J, Min S, Jiaxin Y, Shangzhi H, Yi W, Qifeng W, Xuefeng L, Wenwu H, Xueyan C, Yang L, Zongyao H.
Yehan Z, et al. Among authors: yang l.
Front Immunol. 2024 Apr 25;15:1312380. doi: 10.3389/fimmu.2024.1312380. eCollection 2024.
Front Immunol. 2024.
PMID: 38726002
Free PMC article.